The New England Journal of Medicine
HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   HELP   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 March 13, 2008
 Audio Icon Audio Summary
*
Correspondence
* TP53 Mutations in Head and Neck Cancer
* Cetuximab for Colorectal Cancer
* Addition of Insulin to Oral Therapy in Type 2 Diabetes
* Subgroup Analyses in Clinical Trials
* Methicillin-Resistant Staphylococcus aureus in a Family and Its Pet Cat
*
Book Reviews
* Forgotten Ellis Island: The Extraordinary Story of America's Immigrant Hospital
* Contagious: Cultures, Carriers, and the Outbreak Narrative
* A History of Plastic Surgery
*
Continuing Medical Examination
* Anesthesia Awareness and the Bispectral Index
* EGFR Antagonists in Cancer Treatment
* Case 8-2008: A 33-Year-Old Man with Fever, Abdominal Pain, and Pancytopenia after Renal Transplantation
Original Articles
Anesthesia Awareness and the Bispectral Index

Anesthesia awareness has potential psychological consequences. Use of the bispectral index (BIS) developed from a processed electroencephalogram has been reported to decrease anesthesia awareness. In this randomized, controlled trial comparing a BIS-based protocol with a protocol based on measurement of end-tidal anesthetic gases, two cases of definite anesthesia awareness occurred in each group. This study did not show a benefit of BIS monitoring in reducing the rate of anesthesia awareness.

Related Editorial


Original Articles
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-{alpha}-1,3-Galactose

Immediate hypersensitivity reactions to the monoclonal antibody cetuximab, used for the treatment of colorectal cancer and cancer of the head and neck, were found to be associated with IgE antibodies against cetuximab. These antibodies were present in pretreatment serum and were specific for galactose-{alpha}-1,3-galactose on the heavy chain of the cetuximab monoclonal antibody.


Original Articles
DNA Methylation Markers and Stage I Lung Cancer

Methylation of the promoter region of a gene is a mechanism that influences gene expression. In this study of patients with stage I non–small-cell lung cancer (NSCLC), methylation of seven genes — p16, CDH13, APC, RASSF1A, MGMT, ASC, and DAPK — from tumor and lymph-node specimens was studied. Four genes (p16, CDH13, RASSF1A, and APC), when methylated, were associated with recurrence after surgery with curative intent.


Original Articles
Brief Report: VEGF Inhibition and Renal Thrombotic Microangiopathy

In six patients who received bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor (VEGF), proteinuria subsequently developed, and thrombotic microangiopathy was shown on renal biopsy. In a murine model, the authors showed that using conditional gene targeting to ablate the VEGF gene from renal podocytes can trigger thrombotic microangiopathy. This finding suggests that glomerular injury from bevacizumab may be due to the direct targeting of VEGF.


Special Article
Smoking and Mortality among Adults in India

In this large case–control study in India, the prevalence of smoking was about 5% among women and 37% among men between the ages of 30 and 69 years. Smoking was associated with increased mortality from tuberculosis, respiratory disease, cardiovascular disease, and cancer.


Review Article
Molecular Origins of Cancer: Epigenetics in Cancer

Gene transcription can be activated or inhibited by a reversible modification of the gene; this modification is termed an epigenetic change. This account of epigenetics in cancer reviews the mechanisms and consequences of epigenetic changes in cancer cells and concludes with the implications of these changes for the diagnosis, prognosis, and treatment of cancer.


Review Article
Drug Therapy: EGFR Antagonists in Cancer Treatment

Functional activation of growth factors and receptors of the epidermal growth factor receptor (EGFR) family occurs in most epithelial-cell cancers, rendering EGFR a target for cancer treatment. This article discusses the mechanisms of action of EGFR inhibitors, their anticancer activity, and clinical issues concerning their use in the treatment of patients with cancer.


Case Records of the Massachusetts General Hospital
A 33-Year-Old Man with Fever, Abdominal Pain, and Pancytopenia after Renal Transplantation

A 33-year-old man was admitted to the hospital with fever, abdominal pain, and pancytopenia 15 years after renal transplantation. Imaging studies disclosed hepatosplenomegaly. A diagnostic procedure was performed.


Clinical Implications of Basic Research
Islet Transplantation and Immunosuppression

Experiments using a mouse model of type 1 diabetes indicate that immunosuppressants used in islet transplantation may suppress beta-cell proliferation.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.